IPCI Key Statistics, Chart & Performance
The current stock price of IPCI is 0.2106 null. In the past month the price decreased by -44.58%. In the past year, price decreased by -96.49%.
IPCI Latest News, Press Relases and Analysis
About IPCI
Company Profile
Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.
Company Info
Intellipharmaceutics International Inc.
30 WORCESTER ROAD
TORONTO A6 M9W 5X2
CEO: Isa Odidi
Phone: 416-798-3001
Intellipharmaceutics International Inc. / IPCI FAQ
What does IPCI do?
Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.
Can you provide the latest stock price for Intellipharmaceutics International Inc.?
The current stock price of IPCI is 0.2106 null. The price decreased by -22% in the last trading session.
Does IPCI stock pay dividends?
IPCI does not pay a dividend.
How is the ChartMill rating for Intellipharmaceutics International Inc.?
IPCI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of Intellipharmaceutics International Inc. (IPCI)?
Intellipharmaceutics International Inc. (IPCI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.89).
IPCI Technical Analysis
IPCI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to IPCI. Both the profitability and financial health of IPCI have multiple concerns.
IPCI Financial Highlights
Over the last trailing twelve months IPCI reported a non-GAAP Earnings per Share(EPS) of -2.89. The EPS increased by 0.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -802.68% | ||
| ROA | -119.81% | ||
| ROE | -335.12% | ||
| Debt/Equity | 0 |